The Patent Finder

Biolife Science QLD Limited

Also on record
Records under this name other than the patents Biolife Science QLD Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 3 of 3 · Back to Biolife Science QLD Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,852,604Multiepitope Vaccine for Her2/Neu-Associated Cancers
Lapsed on the fee record
Ended Oct 7, 2026 · High confidence
Lapsed on the fee recordEnded Oct 7, 2026High confidence
US 7,348,010Vaccine Against Cancer Diseases That Are Associated with the HER-2/NEU Oncogene
Term ended
Term ended Apr 17, 2023 · High confidence
Term endedTerm ended Apr 17, 2023High confidence
US 7,166,694Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
Term ended
Term ended Aug 19, 2022 · USPTO record
Term endedTerm ended Aug 19, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited